PI3K Delta and mTOR Inhibitor Compounds for Immune Modulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for effective PI3K inhibitors to address various diseases related to immune system dysfunction and cancer, as existing treatments are inadequate in modulating the PI3K signaling pathway.
Innovation Solution
Development of novel kinase inhibitors, specifically targeting PI3K δ and mTOR, through compounds of specific structural formulas (e.g., Formula I, Formula IX) that inhibit PI3K activity, thereby regulating immune responses and cellular processes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing treatments are used, then current disease management is maintained, but PI3K signaling pathway modulation is inadequate
Solution Approach 1:
The patent modifies the chemical structure of kinase inhibitors by changing molecular parameters such as substituting different heterocyclic groups (pyrazolopyrimidine, triazole, tetrazole) and varying substituent positions to optimize PI3K inhibition while maintaining selectivity. This structural parameter optimization enables effective PI3K signaling pathway modulation that existing treatments fail to achieve.
Solution Approach 2:
The invention introduces specific functional groups at particular positions within the molecule (e.g., R1, R2, R3, R4 substituents on the core heterocyclic structure) to create localized interactions with the PI3K binding site. This local quality enhancement allows the compound to selectively inhibit PI3K δ and mTOR while preserving other kinase activities, thereby improving both reliability and adaptability of the treatment.
2Adaptability or versatility
If novel kinase inhibitors targeting PI3K δ and mTOR are developed, then immune responses and cellular processes are regulated, but compound structural complexity increases
Solution Approach 1:
The patent designs a universal core heterocyclic structure (pyrazolopyrimidine, triazole, or tetrazole) that can perform multiple functions: binding to PI3K δ, binding to mTOR, and providing a scaffold for various substituent groups. This multi-functional core structure enables the single compound to regulate multiple cellular processes including immune responses, cell proliferation, and metabolism, thereby achieving versatility without proportionally increasing complexity.
Solution Approach 2:
The molecule is segmented into distinct functional regions: a core heterocyclic structure for kinase binding, and variable substituent groups (R1-R4) that can be independently optimized. This segmentation allows each part to be designed for its specific function, making the overall complex structure manageable and enabling systematic optimization of immune response regulation while controlling complexity through modular design.
Data Source
AI summary
Chemical entities that modulate PI3 kinase activity, and chemical entities, pharmaceutical compositions, and methods of treatments of diseases and conditions associated with PI3 kinase activity are described herein.